K KNACK PHARMACEUTICALS YOUR HEALTH PARTNER

What this means for you

Not registered yet, but its 24 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

97425841

Mark type

Stylized text

Filed

24 May 2022

Published for opposition

25 Apr 2023

Attorney of record

Tomas M. Casalins

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations for the treatment and prevention of neurodegenerative diseases and disorders; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of pain and neuropathic pain; Pharmaceutical preparations for the treatment and prevention of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of respiratory system diseases and disorders; Pharmaceutical preparations for the treatment and prevention of skin diseases, allergies and rheumatic disorders; Pharmaceutical preparations for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Pharmaceutical preparations for the treatment and prevention of Alzheimer's disease; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of ophthalmic related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of musculoskeletal related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of hormone disorders and deficiencies; Pharmaceutical preparations for the treatment and prevention of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the treatment and prevention of metabolic, endocrine and kidney related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of nausea and vomiting; Pharmaceutical preparations for the treatment and prevention of AIDS-related disorders and diseases; Pharmaceutical preparations for the treatment and prevention of viral and bacterial infections; Pharmaceutical preparations for the treatment of exposure to toxic agents; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the support and promotion of bone strength and health; Pharmaceutical preparations for use as injectable anesthetics; Pharmaceutical preparations for use as contraceptives; Pharmaceutical preparations for fertility enhancement purposes; Pharmaceutical preparations for use in hormone replacement therapy; Pharmaceutical preparations for inducing labor and facilitating nursing; Pharmaceutical preparations, namely, injectable contraceptives
• Class 035 — Advertising and business services: Advertising planning; Advertising services, public relations and marketing services, namely, promoting and marketing the goods and services of others through all public communication means; Business management; Business operation, business administration and office functions

Owner

• Knack Pharmaceuticals, Inc., New York, NY, US
• Knack Pharmaceuticals, Inc., New York, NY, US

Prosecution history

• 10 Dec 2025 — SOU TEAS EXTENSION RECEIVED
• 21 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 20 Jun 2025 — SOU EXTENSION 4 GRANTED
• 20 Jun 2025 — SOU EXTENSION 4 FILED
• 20 Jun 2025 — SOU TEAS EXTENSION RECEIVED
• 13 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 14 Dec 2024 — SOU EXTENSION 3 GRANTED
• 14 Dec 2024 — SOU EXTENSION 3 FILED
• 13 Dec 2024 — SOU TEAS EXTENSION RECEIVED
• 18 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
• 18 Jun 2024 — SOU EXTENSION 2 GRANTED
• 18 Jun 2024 — SOU EXTENSION 2 FILED
• 18 Jun 2024 — SOU TEAS EXTENSION RECEIVED
• 01 May 2024 — ASSIGNED TO EXAMINER
• 21 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED